Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phosphoinositide cycle (PI-cycle) is a central lipid signaling pathway in eukaryotic cells responsible for the synthesis, interconversion, and regeneration of phosphatidylinositol (PI) and its phosphorylated derivatives (phosphoinositides). These molecules act as molecular switches regulating diverse processes including cell signaling, membrane trafficking, cytoskeletal dynamics, and calcium homeostasis. Upon stimulation, enzymes like phospholipase C (PLC) hydrolyze PI(4,5)P₂ into diacylglycerol (DAG) and inositol trisphosphate (IP₃), both acting as secondary messengers. Dysregulation can lead to impaired signal transduction, defective vesicular trafficking, aberrant cell proliferation/cancer, and neurological dysfunctions. Mutations affecting enzymes or regulatory proteins are linked with metabolic disorders and cancers.
Modulation of phosphoinositide synthesis or degradation, affecting downstream signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoinositide Cycle.